Paper
- Alzforum Recommends
Thijssen EH, La Joie R, Wolf A, Strom A, Wang P, Iaccarino L, Bourakova V, Cobigo Y, Heuer H, Spina S, VandeVrede L, Chai X, Proctor NK, Airey DC, Shcherbinin S, Duggan Evans C, Sims JR, Zetterberg H, Blennow K, Karydas AM, Teunissen CE, Kramer JH, Grinberg LT, Seeley WW, Rosen H, Boeve BF, Miller BL, Rabinovici GD, Dage JL, Rojas JC, Boxer AL, Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL) investigators. Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration. Nat Med. 2020 Mar;26(3):387-397. Epub 2020 Mar 2 PubMed.
Biomarker (Source) |
Cohort (N) |
Measurement Mean ± SD |
Method; Assay Name; Manufacturer |
Diagnostic Criteria |
---|---|---|---|---|
Aβ40 (Plasma) |
AD (35) |
245.9 ± 43 pg/mL |
SIMOA; Neurology -plex A; Quanterix |
McKhann et al., 2011 |
Aβ40 (Plasma) |
CTRL- CNC (38) |
248.4 ± 52 pg/mL |
SIMOA; Neurology -plex A; Quanterix |
|
Aβ40 (Plasma) |
FTD- bvFTD (12) |
231.3 ± 40 pg/mL |
SIMOA; Neurology -plex A; Quanterix |
Rascovsky et al., 2011 |
Aβ40 (Plasma) |
PSP (27) |
252.6 ± 50 pg/mL |
SIMOA; Neurology -plex A; Quanterix |
|
Aβ42 (Plasma) |
AD (35) |
19.7 ± 7 pg/mL |
SIMOA; Neurology -plex A; Quanterix |
McKhann et al., 2011 |
Aβ42 (Plasma) |
CTRL- CNC (38) |
21.5 ± 6 pg/mL |
SIMOA; Neurology -plex A; Quanterix |
|
Aβ42 (Plasma) |
FTD- bvFTD (12) |
23.3 ± 6 pg/mL |
SIMOA; Neurology -plex A; Quanterix |
Rascovsky et al., 2011 |
Aβ42 (Plasma) |
PSP (27) |
23.5 ± 8 pg/mL |
SIMOA; Neurology -plex A; Quanterix |
|
NFL (Plasma) |
AD (26) |
20.7 ± 14 pg/mL |
SIMOA; Other/Not Specified; Quanterix |
McKhann et al., 2011 |
NFL (Plasma) |
CBS (32) |
42.6 ± 27 pg/mL |
SIMOA; Other/Not Specified; Quanterix |
|
NFL (Plasma) |
CTRL- CNC (28) |
15.2 ± 8 pg/mL |
SIMOA; Other/Not Specified; Quanterix |
|
NFL (Plasma) |
FTD- bvFTD (40) |
30.3 ± 33 pg/mL |
SIMOA; Other/Not Specified; Quanterix |
Rascovsky et al., 2011 |
NFL (Plasma) |
PSP (45) |
33.8 ± 26 pg/mL |
SIMOA; Other/Not Specified; Quanterix |
|
tau-p181 (CSF) |
AD (16) |
45.8 ± 31 pg/mL |
xMAP; INNO-BIA AlzBio3; Fujirebio |
McKhann et al., 2011 |
tau-p181 (CSF) |
CBS (11) |
22.2 ± 11 pg/mL |
xMAP; INNO-BIA AlzBio3; Fujirebio |
|
tau-p181 (CSF) |
CTRL- CNC (20) |
24.4 ± 12 pg/mL |
xMAP; INNO-BIA AlzBio3; Fujirebio |
|
tau-p181 (Plasma) |
AD (56) |
8.4 ± 4 pg/mL |
Electrochemiluminescence; Other/Not Specified; Lilly/Meso Scale Discovery |
McKhann et al., 2011 |
tau-p181 (Plasma) |
CBS (39) |
2.5 ± 3 pg/mL |
Electrochemiluminescence; Other/Not Specified; Lilly/Meso Scale Discovery |
|
tau-p181 (Plasma) |
CTRL- CNC (69) |
2.4 ± 3 pg/mL |
Electrochemiluminescence; Other/Not Specified; Lilly/Meso Scale Discovery |
|
tau-p181 (Plasma) |
FTD- bvFTD (50) |
1.9 ± 2 pg/mL |
Electrochemiluminescence; Other/Not Specified; Lilly/Meso Scale Discovery |
Rascovsky et al., 2011 |
tau-p181 (Plasma) |
FTD- nfvPPA (27) |
2.7 ± 3 pg/mL |
Electrochemiluminescence; Other/Not Specified; Lilly/Meso Scale Discovery |
Gorno-Tempini et al., 2011 |
tau-p181 (Plasma) |
FTD- svPPA (26) |
2.8 ± 4 pg/mL |
Electrochemiluminescence; Other/Not Specified; Lilly/Meso Scale Discovery |
|
tau-p181 (Plasma) |
PSP (48) |
2.4 ± 3 pg/mL |
Electrochemiluminescence; Other/Not Specified; Lilly/Meso Scale Discovery |
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.